Imatinib induced Stevens-Johnson syndrome: lack of recurrence following re-challenge with a lower dose.
dc.contributor.author | Pavithran, Keechilat | en_US |
dc.contributor.author | Thomas, Mathew | en_US |
dc.date.accessioned | 2009-05-28T08:49:13Z | |
dc.date.available | 2009-05-28T08:49:13Z | |
dc.date.issued | 2005-07-06 | en_US |
dc.description | 14 references. | en_US |
dc.identifier.citation | Pavithran K, Thomas M. Imatinib induced Stevens-Johnson syndrome: lack of recurrence following re-challenge with a lower dose. Indian Journal of Dermatology, Venereology and Leprology. 2005 Jul-Aug; 71(4): 288-9 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/53171 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://www.ijdvl.com | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Antineoplastic Agents --adverse effects | en_US |
dc.subject.mesh | Dose-Response Relationship, Drug | en_US |
dc.subject.mesh | Drug Administration Schedule | en_US |
dc.subject.mesh | Follow-Up Studies | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Leukemia, Myelogenous, Chronic, BCR-ABL Positive --diagnosis | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Piperazines --adverse effects | en_US |
dc.subject.mesh | Pyrimidines --adverse effects | en_US |
dc.subject.mesh | Severity of Illness Index | en_US |
dc.subject.mesh | Stevens-Johnson Syndrome --chemically induced | en_US |
dc.title | Imatinib induced Stevens-Johnson syndrome: lack of recurrence following re-challenge with a lower dose. | en_US |
dc.type | Case Reports | en_US |
dc.type | Letter | en_US |
dc.type | Review | en_US |
Files
License bundle
1 - 1 of 1